Akizawa, T., Shimazaki, R., Shiramoto, M., & Fukagawa, M. (2019). Response to Comments on “Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects: First-in-Human Phase I Study”. Clin Drug Investig.
استشهاد بنمط شيكاغوAkizawa, Tadao, Ryutaro Shimazaki, Masanari Shiramoto, و Masafumi Fukagawa. "Response to Comments On “Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects: First-in-Human Phase I Study”." Clin Drug Investig 2019.
MLA استشهادAkizawa, Tadao, Ryutaro Shimazaki, Masanari Shiramoto, و Masafumi Fukagawa. "Response to Comments On “Pharmacokinetics, Pharmacodynamics, and Safety of the Novel Calcimimetic Agent Evocalcet in Healthy Japanese Subjects: First-in-Human Phase I Study”." Clin Drug Investig 2019.